![Katharine Knobil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katharine Knobil
Direktör/Styrelseledamot på
MARKER THERAPEUTICS, INC.
Förmögenhet: 169 $ per 2026-07-31
Profil
Katharine Knobil is currently an Independent Director at Marker Therapeutics, Inc. since 2021, Director at Infinant Health, Inc., Director at Nimbus Therapeutics LLC, Independent Director at Korro Bio, Inc. since 2024, Member at The National Academies of Science, and Chief Medical Officer at Altesa BioSciences, Inc. Former positions include Independent Director at Arena Pharmaceuticals, Inc. from 2020 to 2022, Director at Patient-Centered Outcomes Research Institute, Director at The National Health Council from 2017 to 2018, Independent Director at Pliant Therapeutics, Inc. from 2022 to 2026, Chief Medical Officer & Senior Vice President at GlaxoSmithKline LLC from 2017 to 2018, Chief Medical Officer, Head-Research & Development at Kaleido Biosciences, Inc. from 2018 to 2021, and Chief Medical Officer at Agilent Technologies, Inc. from 2021 to 2024.
Education includes undergraduate studies at Cornell University and a doctorate from The University of Texas Southwestern Medical Center.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-01 | 150 ( 0 % ) | 170 $ | 2026-07-31 | |
-.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-07-31 |
| 2026-04-15 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Katharine Knobil
| Företag | Position | Start |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-12-08 |
The National Academies of Science
 The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Företagsledare/Principal | - |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Direktör/Styrelseledamot | - |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Teknisk/Vetenskaplig/F&U Direktör | - |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Katharine Knobil
| Företag | Position | Slut |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-06-11 |
| AGILENT TECHNOLOGIES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-01-01 |
| ARENA PHARMACEUTICALS | Direktör/Styrelseledamot | 2022-03-11 |
| KALEIDO BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-01-29 |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Katharine Knobils utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
78
Första gradens relationer
14
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 14 |
|---|---|
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
The National Health Council
 The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Commercial Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Patient-Centered Outcomes Research Institute
 Patient-Centered Outcomes Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization to funds research that helps patients and care takers to make better decisions about their healthcare choices | Commercial Services |
Infinant Health, Inc.
Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
